Last 12 months
Inside the activity.
2 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2022 Filed Jun 17, 2022 21:43 UTC |
ALTMAN MICHAEL SETHDirector
|
GrantStock Option (Right to Buy) · Derivative | 86,467 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001062993-22-015188 · form4.xml · derivative · entry 1 ALTMAN MICHAEL SETH · CIK 0001746738 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,467 Underlying: Common Stock · 86,467 shares Expires 2032-06-15 F1 · derivative.exercise_date: Subject to the reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each vesting date, the shares subject to the Option shall vest on a monthly basis for twelve consecutive months, on the same day of the month as the Grant Date. The Grant Date was June 15, 2022. Read SEC document |
| May 12, 2022 Filed May 13, 2022 17:09 UTC |
Murphy Matthew B.General Counsel
|
GrantCommon Stock | 10,000 | $3.28 | $32,800.00 |
DisclosureSEC source: 0001808805-22-000056 · wf-form4_165247602521861.xml · nonDerivative · entry 1 Murphy Matthew B. · CIK 0001865778 · General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 44,140 F1 · ownership.nature: Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust. Read SEC document |
| May 09, 2022 Filed May 11, 2022 00:28 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
PurchaseCommon Stock | 50,000 | $3.96 | $198,000.00 |
DisclosureSEC source: 0001808805-22-000054 · wf-form4_165222886775160.xml · nonDerivative · entry 1 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,964,488 F1 · price: Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.8299 to $4.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 04, 2022 Filed May 5, 2022 21:04 UTC |
Weld Gwen EChief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 375,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001808805-22-000051 · wf-form4_165178462455955.xml · derivative · entry 1 Weld Gwen E · CIK 0001378831 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2032-05-04 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is April 11, 2022. Read SEC document |
| May 04, 2022 Filed May 5, 2022 21:05 UTC |
Nelson Nicholas A.CBO & Senior VP, Bus. Dev.
|
GrantStock Option (Right to Buy) · Derivative | 54,422 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001808805-22-000052 · wf-form4_165178468439330.xml · derivative · entry 1 Nelson Nicholas A. · CIK 0001857944 · CBO & Senior VP, Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,422 Underlying: Common Stock · 54,422 shares Expires 2032-05-04 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is April 5, 2022. Read SEC document |
| March 30, 2022 Filed Mar 31, 2022 22:16 UTC |
Akinsanya KarenDirector
|
GrantStock Option (Right to Buy) · Derivative | 105,998 | $0.00 Strike: $4.24 | $0.00 |
DisclosureSEC source: 0001808805-22-000033 · wf-form4_164876493974351.xml · derivative · entry 1 Akinsanya Karen · CIK 0001797672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,998 Underlying: Common Stock · 105,998 shares Expires 2032-03-30 F1 · derivative.exercise_date: In connection with the appointment of the Reporting Person to the Issuer's board of directors (the "Board") on March 30, 2022, the Reporting Person automatically received the Option (the "Initial Award") under the Issuer's Outside Director Compensation Policy and in accordance with the Issuer's 2021 Equity Incentive Plan (the "Plan"). Subject to the Reporting Person's continuous status as a "Service Provider" (as defined in the Plan), the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the Initial Award's grant date on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). The grant date is March 30, 2022. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 22:39 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
Exercise / conversionCommon Stock | 100 | $10.00 | $1,000.00 |
DisclosureSEC source: 0001808805-22-000026 · wf-form4_164643353372172.xml · nonDerivative · entry 2 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,914,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 22:39 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001808805-22-000026 · wf-form4_164643353372172.xml · derivative · entry 5 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,733 Underlying: Common Stock · 100 shares Expires 2031-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 31, 2021. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 22:39 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
PurchaseCommon Stock | 50,000 | $3.60 | $179,890.00 |
DisclosureSEC source: 0001808805-22-000026 · wf-form4_164643353372172.xml · nonDerivative · entry 1 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,914,388 F1 · price: Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.57 to $3.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 25, 2022 Filed Feb 25, 2022 20:10 UTC |
Murphy Matthew B.General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001808805-22-000024 · wf-form4_164583778202608.xml · derivative · entry 1 Murphy Matthew B. · CIK 0001865778 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 01:09 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001808805-22-000023 · wf-form4_164583775921533.xml · derivative · entry 1 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 01:09 UTC |
Mallick ParagDirector · Chief Scientist · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001808805-22-000022 · wf-form4_164583773910262.xml · derivative · entry 1 Mallick Parag · CIK 0001857948 · Director · Chief Scientist · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 01:08 UTC |
Sankar SubramanianSenior VP, Product Development
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001808805-22-000021 · wf-form4_164583771063302.xml · derivative · entry 1 Sankar Subramanian · CIK 0001856744 · Senior VP, Product Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 01:08 UTC |
Nelson Nicholas A.CBO & Senior VP, Bus. Dev.
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001808805-22-000020 · wf-form4_164583769017374.xml · derivative · entry 1 Nelson Nicholas A. · CIK 0001857944 · CBO & Senior VP, Bus. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022. Read SEC document |
| February 25, 2022 Filed Feb 26, 2022 01:08 UTC |
Mowry AnnaCFO and Treasurer
|
GrantStock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001808805-22-000019 · wf-form4_164583765686187.xml · derivative · entry 1 Mowry Anna · CIK 0001856938 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2032-02-25 F1 · derivative.exercise_date: Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is February 25, 2022. Read SEC document |
| December 21, 2021 Filed Dec 21, 2021 22:40 UTC |
Mallick ParagDirector · Chief Scientist · 10% owner
|
GiftCommon Stock | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001808805-21-000031 · wf-form4_164012641147342.xml · nonDerivative · entry 1 Mallick Parag · CIK 0001857948 · Director · Chief Scientist · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,479,892 Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:05 UTC |
PERCEPTIVE ADVISORS LLCDirector
EDELMAN JOSEPH10% owner
|
PurchaseCommon Stock | 200,000 | $5.36 | $1,072,000.00 |
DisclosureSEC source: 0000899243-21-047751 · doc4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 9,111,151 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.70, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range. F2 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 02:41 UTC |
Posard Matthew L.Director
|
PurchaseCommon Stock | 10,000 | $4.45 | $44,493.00 |
DisclosureSEC source: 0001808805-21-000026 · wf-form4_163841284890930.xml · nonDerivative · entry 4 Posard Matthew L. · CIK 0001543792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 02:41 UTC |
Posard Matthew L.Director
|
PurchaseCommon Stock | 10,000 | $4.46 | $44,612.00 |
DisclosureSEC source: 0001808805-21-000026 · wf-form4_163841284890930.xml · nonDerivative · entry 3 Posard Matthew L. · CIK 0001543792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 02:41 UTC |
Posard Matthew L.Director
|
PurchaseCommon Stock | 10,000 | $4.50 | $45,000.00 |
DisclosureSEC source: 0001808805-21-000026 · wf-form4_163841284890930.xml · nonDerivative · entry 2 Posard Matthew L. · CIK 0001543792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 13:49 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
PurchaseCommon Stock | 88,022 | $4.73 | $416,396.87 |
DisclosureSEC source: 0001808805-21-000027 · wf-form4_163845298373636.xml · nonDerivative · entry 2 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,864,388 F2 · price: Represents the weighted average share price of an aggregate total of 88,022 shares purchased in the price range of $4.44 to $5.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 02:41 UTC |
Posard Matthew L.Director
|
PurchaseCommon Stock | 20,000 | $4.57 | $91,400.00 |
DisclosureSEC source: 0001808805-21-000026 · wf-form4_163841284890930.xml · nonDerivative · entry 1 Posard Matthew L. · CIK 0001543792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 13:49 UTC |
Patel Sujal MDirector · CEO, President, and Secretary · 10% owner
|
PurchaseCommon Stock | 161,978 | $4.72 | $764,779.13 |
DisclosureSEC source: 0001808805-21-000027 · wf-form4_163845298373636.xml · nonDerivative · entry 1 Patel Sujal M · CIK 0001378830 · Director · CEO, President, and Secretary · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,776,366 F1 · price: Represents the weighted average share price of an aggregate total of 161,978 shares purchased in the price range of $4.48 to $4.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 22:12 UTC |
Mowry AnnaCFO and Treasurer
|
PurchaseCommon Stock | 15,000 | $4.58 | $68,632.50 |
DisclosureSEC source: 0001808805-21-000023 · wf-form4_163779193433755.xml · nonDerivative · entry 1 Mowry Anna · CIK 0001856938 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 F1 · price: Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $4.545 to $4.58 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 15, 2021 Filed Nov 18, 2021 01:19 UTC |
McIlwain Matthew SDirector
|
PurchaseCommon Stock | 100,000 | $5.30 | $529,890.00 |
DisclosureSEC source: 0001062993-21-011100 · form4.xml · nonDerivative · entry 1 McIlwain Matthew S · CIK 0001381752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,075 F1 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $5.16 to $5.36, inclusive. The reporting person undertakes to provide to Nautilus Biotechnology, Inc., any security holder of Nautilus Biotechnology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| August 26, 2021 Filed Aug 26, 2021 23:29 UTC |
McIlwain Matthew SDirector
|
PurchaseCommon Stock | 11,709 | $7.71 | $90,313.86 |
DisclosureSEC source: 0001062993-21-007983 · form4.xml · nonDerivative · entry 3 McIlwain Matthew S · CIK 0001381752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,075 F3 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.67 to $7.75, inclusive. The reporting person undertakes to provide to Nautilus Biotechnology, Inc., any security holder of Nautilus Biotechnology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 23:29 UTC |
McIlwain Matthew SDirector
|
PurchaseCommon Stock | 11,693 | $7.74 | $90,458.22 |
DisclosureSEC source: 0001062993-21-007983 · form4.xml · nonDerivative · entry 2 McIlwain Matthew S · CIK 0001381752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,366 F2 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.69 to $7.75, inclusive. The reporting person undertakes to provide to Nautilus Biotechnology, Inc., any security holder of Nautilus Biotechnology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 23:29 UTC |
McIlwain Matthew SDirector
|
PurchaseCommon Stock | 13,568 | $7.68 | $104,268.72 |
DisclosureSEC source: 0001062993-21-007983 · form4.xml · nonDerivative · entry 1 McIlwain Matthew S · CIK 0001381752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,673 F1 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.56 to $7.75, inclusive. The reporting person undertakes to provide to Nautilus Biotechnology, Inc., any security holder of Nautilus Biotechnology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| August 13, 2021 Filed Aug 13, 2021 21:01 UTC |
Murphy Matthew B.General Counsel
|
PurchaseCommon Stock | 5,000 | $7.56 | $37,806.50 |
DisclosureSEC source: 0001808805-21-000010 · wf-form4_162890281874630.xml · nonDerivative · entry 1 Murphy Matthew B. · CIK 0001865778 · General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 34,140 F1 · ownership.direct: Shares held by the Murphy Family Trust. The Reporting Person is the Trustee of the Murphy Family Trust. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:12 UTC |
Mowry AnnaCFO and Treasurer
|
PurchaseCommon Stock | 17,500 | $7.71 | $134,925.00 |
DisclosureSEC source: 0001808805-21-000012 · wf-form4_162914834553171.xml · nonDerivative · entry 1 Mowry Anna · CIK 0001856938 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F1 · price: Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $7.60 to $7.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 14, 2021 Filed Aug 4, 2021 20:01 UTC |
Murphy Matthew B.General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 326,526 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001628280-21-015647 · wf-form4_162812167372819.xml · derivative · entry 1 Murphy Matthew B. · CIK 0001865778 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,526 Underlying: Common Stock · 326,526 shares Expires 2031-06-14 F1 · derivative.exercise_date: Subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan), 25% of the shares subject to such Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date (as defined below), and the balance of the shares subject to such Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary. The Vesting Commencement Date is April 1, 2021. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:45 UTC |
PERCEPTIVE ADVISORS LLCFormer Director
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDFormer Director
EDELMAN JOSEPHFormer Director
|
OtherCommon Stock | 2,914,113 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-21-005576 · form4.xml · nonDerivative · entry 3 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Former Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Former Director EDELMAN JOSEPH · CIK 0001164426 · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 8,911,151 F2 · price: Acquired pursuant to the business combination by and among ARYA Sciences Acquisition Corp III, Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. ("Old Nautilus") in exchange for shares of Old Nautilus previously held by the Master Fund. F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:45 UTC |
PERCEPTIVE ADVISORS LLCFormer Director
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDFormer Director
EDELMAN JOSEPHFormer Director
|
PurchaseCommon Stock | 5,500,000 | $10.00 | $55,000,000.00 |
DisclosureSEC source: 0001062993-21-005576 · form4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Former Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Former Director EDELMAN JOSEPH · CIK 0001164426 · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,997,038 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:32 UTC |
ALTMAN MICHAEL SETHDirector
|
GrantStock Option (Right to buy) · Derivative | 44,435 | $0.00 Strike: $11.16 | $0.00 |
DisclosureSEC source: 0001140361-21-020674 · form4.xml · derivative · entry 5 ALTMAN MICHAEL SETH · CIK 0001746738 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,435 Underlying: Common Stock · 44,435 shares Expires 2031-06-09 F4 · security: In connection with the appointment of the Reporting Person to the board of directors of Nautilus (the "Board"), the Board granted on June 9, 2021 the Reporting Person an Initial Award (as defined in the Company's Outside Director Compensation Policy and in accordance with Nautilus' 2021 Equity Incentive Plan (the "Plan"). Subject to the Reporting Person's continuous status as a "Service Provider" (as defined in the the Plan), the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the Initial Award's grant date on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). The grant date is June 9, 2021. F4 · kind: In connection with the appointment of the Reporting Person to the board of directors of Nautilus (the "Board"), the Board granted on June 9, 2021 the Reporting Person an Initial Award (as defined in the Company's Outside Director Compensation Policy and in accordance with Nautilus' 2021 Equity Incentive Plan (the "Plan"). Subject to the Reporting Person's continuous status as a "Service Provider" (as defined in the the Plan), the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the Initial Award's grant date on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). The grant date is June 9, 2021. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:32 UTC |
ALTMAN MICHAEL SETHDirector
|
ConversionClass B ordinary shares · Derivative | 3,647,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-020674 · form4.xml · derivative · entry 4 ALTMAN MICHAEL SETH · CIK 0001746738 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ARYA Sciences Holdings III Disclosed balance after: 0 Underlying: Class A ordinary shares · 3,647,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F1 · kind: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F1 · price: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F1 · derivative.exercise_date: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F1 · derivative.expiration_date: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.nature: The securities reported herein are held by the Sponsor. The Sponsor is governed by a board of directors consisting of two directors, Adam Stone and Michael Altman (the "Reporting Person"). As such, Mr. Stone and the Reporting Person have voting and investment discretion with respect to securities held of record by the Sponsor and may be deemed to have shared beneficial ownership of the securities held directly by the Sponsor. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:32 UTC |
ALTMAN MICHAEL SETHDirector
|
ConversionCommon Stock | 499,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-020674 · form4.xml · nonDerivative · entry 3 ALTMAN MICHAEL SETH · CIK 0001746738 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ARYA Sciences Holdings III Disclosed balance after: 499,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: In connection with the Business Combination, the Sponsor's private placement shares, par value $0.0001 per share, of ARYA automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F3 · price: In connection with the Business Combination, the Sponsor's private placement shares, par value $0.0001 per share, of ARYA automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.nature: The securities reported herein are held by the Sponsor. The Sponsor is governed by a board of directors consisting of two directors, Adam Stone and Michael Altman (the "Reporting Person"). As such, Mr. Stone and the Reporting Person have voting and investment discretion with respect to securities held of record by the Sponsor and may be deemed to have shared beneficial ownership of the securities held directly by the Sponsor. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:32 UTC |
ALTMAN MICHAEL SETHDirector
|
ConversionClass A ordinary shares | 499,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-020674 · form4.xml · nonDerivative · entry 2 ALTMAN MICHAEL SETH · CIK 0001746738 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ARYA Sciences Holdings III Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: In connection with the Business Combination, the Sponsor's private placement shares, par value $0.0001 per share, of ARYA automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F3 · price: In connection with the Business Combination, the Sponsor's private placement shares, par value $0.0001 per share, of ARYA automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.nature: The securities reported herein are held by the Sponsor. The Sponsor is governed by a board of directors consisting of two directors, Adam Stone and Michael Altman (the "Reporting Person"). As such, Mr. Stone and the Reporting Person have voting and investment discretion with respect to securities held of record by the Sponsor and may be deemed to have shared beneficial ownership of the securities held directly by the Sponsor. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:32 UTC |
ALTMAN MICHAEL SETHDirector
|
ConversionCommon Stock | 3,647,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-21-020674 · form4.xml · nonDerivative · entry 1 ALTMAN MICHAEL SETH · CIK 0001746738 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ARYA Sciences Holdings III Disclosed balance after: 3,647,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F1 · price: In connection with the Business Combination Agreement, dated February 7, 2021, by and among ARYA Sciences Acquisition Corp III ("ARYA"), Mako Merger Sub, Inc. and Nautilus Biotechnology, Inc. (the transactions contemplated thereby, the "Business Combination"), ARYA domesticated as a Delaware corporation (the "Domestication") and changed its name to "Nautilus Biotechnology, Inc." ("Nautilus"). In connection with the Domestication, ARYA Sciences Holdings III's (the "Sponsor") Class B ordinary shares, par value $0.0001 per share, of ARYA, which were previously convertible into Class A ordinary shares of ARYA (as described in ARYA's registration statement on Form S-1 (File No. 333-239986) under the heading "Description of Securities--Founder Shares"), were automatically converted into shares of common stock of Nautilus, par value $0.0001 per share, on a one-for-one basis. F2 · ownership.nature: The securities reported herein are held by the Sponsor. The Sponsor is governed by a board of directors consisting of two directors, Adam Stone and Michael Altman (the "Reporting Person"). As such, Mr. Stone and the Reporting Person have voting and investment discretion with respect to securities held of record by the Sponsor and may be deemed to have shared beneficial ownership of the securities held directly by the Sponsor. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| June 03, 2021 Filed Jun 3, 2021 22:55 UTC |
PERCEPTIVE ADVISORS LLCDirector
EDELMAN JOSEPHDirector
|
PurchaseClass A Ordinary Shares | 330,050 | $10.05 | $3,317,002.50 |
DisclosureSEC source: 0001062993-21-005377 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director EDELMAN JOSEPH · CIK 0001164426 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 489,975 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.01 to $10.15, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range. F2 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| May 24, 2021 Filed Jun 11, 2021 21:45 UTC |
PERCEPTIVE ADVISORS LLCFormer Director
PERCEPTIVE LIFE SCIENCES MASTER FUND LTDFormer Director
EDELMAN JOSEPHFormer Director
|
PurchaseCommon Stock | 7,063 | $10.05 | $70,983.15 |
DisclosureSEC source: 0001062993-21-005576 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Former Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Former Director EDELMAN JOSEPH · CIK 0001164426 · Former Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,038 Read SEC document |
| May 20, 2021 Filed May 24, 2021 22:49 UTC |
PERCEPTIVE ADVISORS LLCDirector
EDELMAN JOSEPHDirector
|
PurchaseClass A Ordinary Shares | 159,925 | $10.05 | $1,607,246.25 |
DisclosureSEC source: 0001062993-21-005014 · form4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · Director PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · Director EDELMAN JOSEPH · CIK 0001164426 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 159,925 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 00:48 UTC |
ARYA Sciences Holdings III10% owner
|
OtherClass A ordinary shares | 499,000 | $10.00 | $4,990,000.00 |
DisclosureSEC source: 0001140361-20-018164 · form4.xml · nonDerivative · entry 1 ARYA Sciences Holdings III · CIK 0001808802 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,000 F1 · kind: The reported Class A ordinary shares were purchased as Private Placement Shares by ARYA Sciences Holdings III (the "Sponsor") for $10.00 per share, as described under the heading "Description of Securities " in the Issuer's registration statement on Form S-1 (File No. 333- 239986). Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 00:43 UTC |
Stone Adam LeoDirector · Chief Executive Officer · 10% owner
|
OtherClass A ordinary shares | 499,000 | $10.00 | $4,990,000.00 |
DisclosureSEC source: 0001140361-20-018162 · form4.xml · nonDerivative · entry 1 Stone Adam Leo · CIK 0001727440 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By ARYA Sciences Holdings III Disclosed balance after: 499,000 F1 · kind: The reported Class A ordinary shares were purchased as Private Placement Shares by ARYA Sciences Holdings III (the "Sponsor") for $10.00 per share, as described under the heading "Description of Securities " in the Issuer's registration statement on Form S-1 (File No. 333- 239986). F2 · ownership.nature: The securities reported herein are held by the Sponsor. The Sponsor is governed by a board of directors consisting of two directors, the Reporting Person and Michael Altman. As such, the Reporting Person and Mr. Altman have voting and investment discretion with respect to the Class A ordinary shares held of record by the Sponsor and may be deemed to have shared beneficial ownership of the Class A ordinary shares held directly by the Sponsor. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 00:38 UTC |
ALTMAN MICHAEL SETHDirector · Chief Financial Officer · 10% owner
|
OtherClass A ordinary shares | 499,000 | $10.00 | $4,990,000.00 |
DisclosureSEC source: 0001140361-20-018160 · form4.xml · nonDerivative · entry 1 ALTMAN MICHAEL SETH · CIK 0001746738 · Director · Chief Financial Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By ARYA Sciences Holdings III Disclosed balance after: 499,000 F1 · kind: The reported Class A ordinary shares were purchased as Private Placement Shares by ARYA Sciences Holdings III (the "Sponsor") for $10.00 per share, as described under the heading "Description of Securities " in the Issuer's registration statement on Form S-1 (File No. 333- 239986). F2 · ownership.nature: The securities reported herein are held by the Sponsor. The Sponsor is governed by a board of directors consisting of two directors, Adam Stone and the Reporting Person. As such, Mr. Stone and the Reporting Person have voting and investment discretion with respect to the Class A ordinary shares held of record by the Sponsor and may be deemed to have shared beneficial ownership of the Class A ordinary shares held directly by the Sponsor. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.